It is a chemicals and materials private limited company based in Delhi, Delhi, India, established in 2004.
2004 | Delhi, Delhi, India | ActiveMickle Felix Pharmaceuticals Private Limited, a active private limited company, was established on 19 March 2004 in Delhi, Delhi, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24239DL2004PTC125291. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹4.00 Cr.
Formerly known as Niramaya Pharmaceuticals Private Limited. It upholds a compliant status. Employing 11 professional, Its leadership includes Gurcharan Singh (Director), Mohinder Singh (Director), Gajendra Singh Shekhawat (Director). Past directors included Harchran Singh, Darvinder Kumar, Gurcharan Singh. It holds no open charges and ₹4.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 103, Friends Complex, E-7A, Jawahar Park, Laxmi Nagar,, Delhi, Delhi, 110092.
U24239DL2004PTC125291
125291
19 March 2004
₹4.00 Cr
₹4.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Mickle Felix Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gurcharan Singh | Director | 01 Jan 2014 | Current |
| Mohinder Singh | Director | 02 Apr 2021 | Current |
| Gajendra Singh Shekhawat | Director | 25 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Apr 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Secretary | - | Past |
| Pramod Abcsdd | Director | 31 Dec 2014 | Past |
| Pramod Abcsdd | Director | 31 May 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mickle Felix Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 96.93% decrease. The company also saw a substantial fall in profitability, with a 25.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Mickle Felix Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹40,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2004 | Punjab National Bank | ₹4.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Mickle Felix Pharmaceuticals has a workforce of 11 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mickle Felix Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mickle Felix Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Mickle Felix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Gajendra Singh Shekhawat was appointed as a Director was appointed as a Director on 25 Sep 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
Progress on Mickle Felix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Mohinder Singh was appointed as a Director was appointed as a Director on 02 Apr 2021 & has been associated with this company since 4 years 8 months . was recorded as a recent event.
The activity A charge registered on 15 Dec 2004 via Charge ID 90039623 with Punjab National Bank was fully satisfied on 26 Nov 2014. was completed.
The activity Gurcharan Singh was appointed as a Director was appointed as a Director on 01 Jan 2014 & has been associated with this company since 11 years 11 months . was completed.
The CIN of Mickle Felix Pharmaceuticals Private Limited is U24239DL2004PTC125291.
Mickle Felix Pharmaceuticals Private Limited is headquartered at 103, Friends Complex, E-7A, Jawahar Park, Laxmi Nagar,, Delhi, Delhi, 110092.
Mickle Felix Pharmaceuticals Private Limited was incorporated on 19 March 2004.
The current directors of Mickle Felix Pharmaceuticals Private Limited are
The primary industry of Mickle Felix Pharmaceuticals Private Limited is Manufacturing.
Mickle Felix Pharmaceuticals Private Limited is unlisted.
The authorized capital of Mickle Felix Pharmaceuticals Private Limited is ₹4.00 Cr, and the paid-up capital is ₹4.00 Cr.
The compliance status of Mickle Felix Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX